Literature DB >> 24641906

Rethinking risk: gender and injection drug-related HIV risk among female sex workers and their non-commercial partners along the Mexico-U.S. border.

Jennifer L Syvertsen1, Angela M Robertson2, Steffanie A Strathdee3, Gustavo Martinez4, M Gudelia Rangel5, Karla D Wagner6.   

Abstract

BACKGROUND: Studies of injection drug-using couples suggest a gendered performance of risk in which men exert greater control over drug use and render their female partners vulnerable to HIV infection and other negative health outcomes. This study assesses gender roles in injection drug use as practiced among female sex workers and their intimate male partners within a risk environment marked by rapid socioeconomic changes.
METHODS: We draw on quantitative surveys, semi-structured interviews, and ethnographic fieldwork conducted as part of cohort study of HIV/STI risk among female sex workers and their intimate, non-commercial partners along the Mexico-U.S. border. This study employed descriptive statistics and inductive analyses of transcripts and field notes to examine practices related to drug procurement, syringe sharing, and injection assistance among couples in which both partners reported injecting drugs in the past 6 months.
RESULTS: Among 156 couples in which both partners injected drugs (n=312), our analyses revealed that women's roles in drug use were active and multidimensional, and both partners' injection risk practices represented embodied forms of cooperation and compassion. Women often earned money to purchase drugs and procured drugs to protect their partners from the police. Sharing drugs and syringes and seeking injection assistance were common among couples due to drug market characteristics (e.g., the use of "black tar" heroin that clogs syringes and damages veins). Both women and men provided and received injection assistance, which was typically framed as caring for the partner in need of help.
CONCLUSION: Our mixed methods study suggests that in certain risk environments, women are more active participants in injection-related practices than has often been revealed. This participation is shaped by dynamic relationship and structural factors. Our suggestion to consider gendered injection risk as a nuanced and relational process has direct implications for future research and interventions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Couples; Gender; HIV; Injection drug use; Mexico

Mesh:

Year:  2014        PMID: 24641906      PMCID: PMC4133300          DOI: 10.1016/j.drugpo.2014.02.005

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  61 in total

1.  Injection drug use and despair through the lens of gender.

Authors:  P M Spittal; M T Schechter
Journal:  CMAJ       Date:  2001-03-20       Impact factor: 8.262

Review 2.  Structural interventions to reduce HIV transmission among injecting drug users.

Authors:  D C Des Jarlais
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

3.  Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003.

Authors:  Courtney Breen; Amanda Roxburgh; Louisa Degenhardt
Journal:  Drug Alcohol Rev       Date:  2005-07

4.  Can't buy my love: a typology of female sex workers' commercial relationships in the Mexico-U.S. Border Region.

Authors:  Angela M Robertson; Jennifer L Syvertsen; Hortensia Amaro; Gustavo Martinez; M Gudelia Rangel; Thomas L Patterson; Steffanie A Strathdee
Journal:  J Sex Res       Date:  2013-05-09

5.  Managing la malilla: Exploring drug treatment experiences among injection drug users in Tijuana, Mexico, and their implications for drug law reform.

Authors:  Jennifer Syvertsen; Robin A Pollini; Remedios Lozada; Alicia Vera; Gudelia Rangel; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2010-08-25

6.  Needle sharing in context: patterns of sharing among men and women injectors and HIV risks.

Authors:  M A Barnard
Journal:  Addiction       Date:  1993-06       Impact factor: 6.526

7.  Interdisciplinary mixed methods research with structurally vulnerable populations: case studies of injection drug users in San Francisco.

Authors:  Andrea M Lopez; Philippe Bourgois; Lynn D Wenger; Jennifer Lorvick; Alexis N Martinez; Alex H Kral
Journal:  Int J Drug Policy       Date:  2013-01-09

8.  'Where sex ends and emotions begin': love and HIV risk among female sex workers and their intimate, non-commercial partners along the Mexico-US border.

Authors:  Jennifer L Syvertsen; Angela M Robertson; Lawrence A Palinkas; M Gudelia Rangel; Gustavo Martinez; Steffanie A Strathdee
Journal:  Cult Health Sex       Date:  2013-03-11

9.  Heroin in brown, black and white: structural factors and medical consequences in the US heroin market.

Authors:  Daniel Ciccarone
Journal:  Int J Drug Policy       Date:  2008-10-21

10.  Women's drug injection practices in East Harlem: an event analysis in a high-risk community.

Authors:  Stephanie Tortu; James M McMahon; Rahul Hamid; Alan Neaigus
Journal:  AIDS Behav       Date:  2003-09
View more
  14 in total

1.  Gendered violence and overdose prevention sites: a rapid ethnographic study during an overdose epidemic in Vancouver, Canada.

Authors:  Jade Boyd; Alexandra B Collins; Samara Mayer; Lisa Maher; Thomas Kerr; Ryan McNeil
Journal:  Addiction       Date:  2018-09-14       Impact factor: 6.526

2.  Men in Community Correction Programs and Their Female Primary Sex Partners: Latent Class Analysis to Identify the Relationship of Clusters of Drug Use and Sexual Behaviors and HIV Risks.

Authors:  Nabila El-Bassel; Alissa Davis; Amar Mandavia; Dawn Goddard-Eckrich; Timothy Hunt; Phillip Marotta; Mingway Chang; Elwin Wu; Louisa Gilbert
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

3.  The Influence of PrEP-Related Stigma and Social Support on PrEP-Use Disclosure among Women Who Inject Drugs and Social Network Members.

Authors:  Marisa Felsher; Karley Dutra; Brent Monseur; Alexis M Roth; Carl Latkin; Oluwaseun Falade-Nwulia
Journal:  AIDS Behav       Date:  2021-05-20

4.  An Exploration of Pre-exposure Prophylaxis (PrEP) Initiation Among Women Who Inject Drugs.

Authors:  Marisa Felsher; Eliza Ziegler; Laramie R Smith; Susan G Sherman; K Rivet Amico; Rachel Fox; Kayla Madden; Alexis M Roth
Journal:  Arch Sex Behav       Date:  2020-04-09

5.  Place of Residence Moderates the Relationship Between Emotional Closeness and Syringe Sharing Among Injection Drug Using Clients of Sex Workers in the US-Mexico Border Region.

Authors:  Karla D Wagner; Eileen V Pitpitan; Thomas W Valente; Steffanie A Strathdee; Melanie Rusch; Carlos Magis-Rodriguez; Claudia V Chavarin; Thomas L Patterson
Journal:  AIDS Behav       Date:  2015-06

6.  "Generally, you get 86'ed because you're a liability": An application of Integrated Threat Theory to frequently witnessed overdoses and social distancing responses.

Authors:  J M Bowles; L R Smith; S R Verdugo; K D Wagner; P J Davidson
Journal:  Soc Sci Med       Date:  2020-07-09       Impact factor: 4.634

7.  Strategies for recruiting steady male partners of female sex workers for HIV research.

Authors:  Paul J Fleming; Clare Barrington; Martha Perez; Yeycy Donastorg; Deanna Kerrigan
Journal:  AIDS Behav       Date:  2015-02

8.  The micro-social risk environment for injection drug use: An event specific analysis of dyadic, situational, and network predictors of injection risk behavior.

Authors:  Patrick Janulis
Journal:  Int J Drug Policy       Date:  2015-10-31

9.  HIV Transmission Networks in the San Diego-Tijuana Border Region.

Authors:  Sanjay R Mehta; Joel O Wertheim; Kimberly C Brouwer; Karla D Wagner; Antoine Chaillon; Steffanie Strathdee; Thomas L Patterson; Maria G Rangel; Mlenka Vargas; Ben Murrell; Richard Garfein; Susan J Little; Davey M Smith
Journal:  EBioMedicine       Date:  2015-07-18       Impact factor: 8.143

10.  A qualitative analysis of transitions to heroin injection in Kenya: implications for HIV prevention and harm reduction.

Authors:  Andy Guise; Margarita Dimova; James Ndimbii; Phil Clark; Tim Rhodes
Journal:  Harm Reduct J       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.